NEW GOODRX REPORT UNDERSCORES NEED FOR CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE

Latest Data Finds List Prices of Prescription Drug Prices Have Increased Read More

SECOND OPINION: LATEST PHRMA AD CAMPAIGN DEFENDS PATENT ABUSE “STATUS QUO”

Big Pharma Advertising Blitz Seeks to Protect Anti-Competitive Tactics That Read More

DOSE OF REALITY: FORBES: HOW BIG PHARMA EXPLOITS LOOPHOLES IN THE PATENT SYSTEM

Avik Roy Highlights How Increased USPTO-FDA Collaboration and Greater Scrutiny Read More

DOSE OF REALITY: FORBES: HOW BIG PHARMA STIFLES COMPETITION WITH PRODUCT SHOPPING

Research Column Explores Case Study in Common Patent Abuse Tactic That Read More

BIG PHARMA EARNINGS WATCH: ELI LILLY, NOVO NORDISK, ABBVIE, AMGEN, GLAXOSMITHKLINE AND PFIZER

Repeated Price Hikes and Egregious Prices on GLP-1 Weight Loss Drugs Boost Read More